Release van documentaire over Heparine: honderdjarig medicijn dat jaarlijks 100 miljoen levens redt
BARCELONA–(BUSINESS WIRE)– “Iedereen kent penicilline, maar niemand weet wat heparine is, noch dat heparine in de twintigste eeuw evenveel levens heeft gered als penicilline”, zegt hoogleraar Coen Hemker, biochemicus en emeritus hoogleraar aan Universiteit van Maastricht aan het begin van de documentaire Heparin: 100 years saving lives. De audiovisuele opnames van 30 minuten is geregisseerd door Carles Canet, geproduceerd door Broadcaster en gepromoot door Bioibérica. De video beschrijft op basis van persoonlijke ervaringen waarom dit antistollingsmiddel dusdanig belangrijk is binnen de moderne geneeskunde dat het door de Wereldgezondheidsorganisatie is uitgeroepen tot een prioriteitsmedicijn.
The Release of the First Documentary Dedicated to Heparin: a Centenary Drug That Saves over One Hundred Million Lives Each Year |
|||||
|
BARCELONA–(BUSINESS WIRE)– “ Everybody has heard of penicillin, but nobody knows what heparin is. And the fact is that heparin has saved as many lives as penicillin in the course of the 20 th century”, explains Prof. Coen Hemker, a biochemist and Emeritus of the University of Maastricht, at the start of the documentary “Heparin: 100 years saving lives”. This 30-minute audiovisual recording has been directed by Carles Canet and produced by Broadcaster, with promotion from Bioibérica, to describe – on the basis of personal experiences – this anticoagulant drug which is so important in modern Medicine, having been declared a first-need drug by the World Health Organization. In effect, this is the first documentary dedicated to this drug, and has been able to join the leading specialists and investigators in Hematology, Cardiology and Surgery, among other fields, as well as the drug industry, within one same audiovisual recording. Professionals from Spain ( Hospital de la Santa Creu i Sant Pau, Hospital Universitari General de Catalunya, Hospital Germans Trias i Pujol, Banc de Sang i Teixits, Instituto Valenciano de Fertilidad, ISGlobal, IBEC), the United States ( Baylor University, Rensselaer Polytechnic Institute), The Netherlands (Universidad de Maastricht, Synapse Research Institute) and Italy (Instituto Ronzoni), as well as international companies such as Sanofi, Laboratorios Rovi, BBraun or Bioibérica, have participated in the initiative But the true central characters of this documentary are the patients who explain their own experiences: “ I found it impossible to finish a training session and couldn’t believe that I would have to abandon water polo because of a clot in the subclavian vein at 17 years of age. Thanks to heparin, I was able to recover after six months, and everything that came afterwards was very much worthwhile”, explains Jennifer Pareja, a Spanish water polo player nominated the best player in the world in 2013. The documentary can be seen online on Bioiberica website and is open to all those entities, educational institutions, organizations and people who wish to use and diffuse the recording. “Five out of every 10 people will need heparin at some point in life. Medicine wouldn’t be where it is today without it”, explains Professor James Marcum, a historian at Baylor University in the United States. Heparin, discovered in 1916, is a highly sulfated glycosaminoglycan – a natural substance composed of various molecules that inhibits blood clotting. Because of these properties, heparin is currently the most widely used drug for preventing and treating thrombosis. According to the International Society on Thrombosis and Hemostasis, one out of every four people in the world die of causes related to this disorder, which now produces more deaths each year than AIDS, breast cancer and traffic accidents combined. View source version on businesswire.com: http://www.businesswire.com/news/home/20170309005559/en/ Contacts Bioibérica |
|||||